TIMP-1 gene expression and PAI-1 antigen after unilateral ureteral obstruction in the adult male rat.
暂无分享,去创建一个
S. Dauwe | M. D. de Broe | G. Verpooten | K. D. De Greef | D. Ysebaert | G. Verpooten | M. Broe | K. D. Greef | C. Duymelinck | M. De broe
[1] H. S. Kim,et al. Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice. , 1999, The Journal of clinical investigation.
[2] G. González-Ávila,et al. Changes in Matrix Metalloproteinases during the Evolution of Interstitial Renal Fibrosis in a Rat Experimental Model , 1998, Pathobiology.
[3] S. Dauwe,et al. Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy. , 1998, Kidney international.
[4] R. Atkins,et al. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. , 1998, Kidney international.
[5] B. Yang,et al. Cellular apoptosis and proliferation in experimental renal fibrosis. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[6] P. Higgins,et al. Cell shape‐dependent pathway of plasminogen activator inhibitor type‐1 gene expression requires cytoskeletal reorganization , 1998, Journal of cellular physiology.
[7] L. Truong,et al. Chronic obstructive uropathy in severe combined immunodeficient (SCID) mice: lymphocyte infiltration is not required for progressive tubulointerstitial injury. , 1998, Journal of the American Society of Nephrology : JASN.
[8] G. D. De Meyer,et al. RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. , 1998, The American journal of pathology.
[9] J. Loffing,et al. Postnatal maturation of renal cortical peritubular fibroblasts in the rat , 1998, Anatomy and Embryology.
[10] F. Morel,et al. Inter-regulated balance between gelatinases and tissue inhibitor (TIMP-1) in isolated human glomeruli. , 1998, Renal failure.
[11] T. Shirasawa,et al. Mizoribine improves renal tubulointerstitial fibrosis in unilateral ureteral obstruction (UUO)-treated rat by inhibiting the infiltration of macrophages and the expression of alpha-smooth muscle actin. , 1997, The Journal of urology.
[12] S. Klahr,et al. Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring. , 1997, Kidney international. Supplement.
[13] D. Gomez,et al. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. , 1997, European journal of cell biology.
[14] S. Klahr. Remarks on behalf of the new editorial team of Kidney International , 1997 .
[15] M. Gubler,et al. Development of human fetal kidney in obstructive uropathy: correlations with ultrasonography and urine biochemistry. , 1997, Kidney international.
[16] S. Dauwe,et al. Cholesterol feeding accentuates the cyclosporine-induced elevation of renal plasminogen activator inhibitor type 1. , 1997, Kidney international.
[17] M. Brezis,et al. Renal microcirculation and tissue damage during acute ureteral obstruction in the rat: effect of saline infusion, indomethacin and radiocontrast. , 1997, Kidney international.
[18] D. Vaughan,et al. Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. , 1997, Kidney international.
[19] A. Eddy. Interstitial inflammation and fibrosis in rats with diet-induced hypercholesterolemia. , 1996, Kidney international.
[20] L. Truong,et al. Cell apoptosis and proliferation in experimental chronic obstructive uropathy. , 1996, Kidney international.
[21] S. Klahr,et al. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. , 1996, Kidney international.
[22] M. Martínez-Maldonado,et al. Role of angiotensin II in the expression and regulation of transforming growth factor-β in obstructive nephropathy , 1995 .
[23] S. El-Dahr,et al. Sequential changes in renal expression of renin-angiotensin system genes in acute unilateral ureteral obstruction. , 1995, Kidney international.
[24] R. Atkins,et al. Local macrophage proliferation in the progression of glomerular and tubulointerstitial injury in rat anti-GBM glomerulonephritis. , 1995, Kidney international.
[25] G. Pelz,et al. Evidence for the tissue inhibitor of metalloproteinases-1 (TIMP-1) in human polymorphonuclear leukocytes. , 1995, European journal of biochemistry.
[26] J. Diamond. Macrophages and progressive renal disease in experimental hydronephrosis. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[27] A. Michael,et al. Altered expression of matrix metalloproteinase-2, TIMP, and TIMP-2 in obstructive nephropathy. , 1995, The Journal of laboratory and clinical medicine.
[28] S. Klahr,et al. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. , 1995, Kidney international.
[29] H. van Goor,et al. Differential mRNA expression of renal cortical tissue inhibitor of metalloproteinase-1, -2, and -3 in experimental hydronephrosis. , 1995, Journal of the American Society of Nephrology : JASN.
[30] A. Eddy. Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. , 1994, Journal of the American Society of Nephrology : JASN.
[31] P. Basset,et al. Cloning of the cDNA encoding rat tissue inhibitor of metalloproteinase 1 (TIMP-1), amino acid comparison with other TIMPs, and gene expression in rat tissues. , 1994, Gene.
[32] K. Iwata,et al. Growth‐promoting activity of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for a wide range of cells A possible new growth factor in serum , 1992, FEBS letters.
[33] M. Post,et al. Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis. , 1991, Kidney international.
[34] D. Belin,et al. The plasminogen activator/plasmin system. , 1991, The Journal of clinical investigation.
[35] W. Schürch,et al. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[36] S. Klahr,et al. Eicosanoid production by isolated glomeruli of rats with unilateral ureteral obstruction. , 1990, Kidney international.
[37] J. Verhoeven,et al. Evaluation of the LOGIC system for the rapid identification of members of the family Enterobacteriaceae in the clinical microbiology laboratory , 1990, Journal of Clinical Microbiology.
[38] S. Klahr,et al. Effect of leukocyte depletion on the function of the postobstructed kidney in the rat. , 1989, Kidney international.
[39] P. Meylan,et al. Relationship between neutrophil-mediated oxidative injury during acute experimental pyelonephritis and chronic renal scarring , 1989, Infection and immunity.
[40] S. Klahr,et al. Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney. , 1988, Kidney international.
[41] Y. DeClerck. Purification and characterization of a collagenase inhibitor produced by bovine vascular smooth muscle cells. , 1988, Archives of biochemistry and biophysics.
[42] G. González-Ávila,et al. Experimental diffuse interstitial renal fibrosis. A biochemical approach. , 1988, Laboratory investigation; a journal of technical methods and pathology.
[43] M. Alessi,et al. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. , 1988, Blood.
[44] G. Gobe,et al. Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Role of apoptosis. , 1987, Laboratory investigation; a journal of technical methods and pathology.
[45] P. Meylan,et al. Influence of inflammation on the efficacy of antibiotic treatment of experimental pyelonephritis , 1986, Antimicrobial Agents and Chemotherapy.
[46] E. Döpp,et al. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in rat recognized by monoclonal antibodies ED1, ED2 and ED3. , 1985, Advances in experimental medicine and biology.
[47] T. Nagai. Morphologic and immunohistologic study of pyelonephritis in rats by various bacteria and fungi. Special reference to inflammatory changes and localization of antigen. , 1984, Nephron.
[48] S. Klahr,et al. Pathophysiology of obstructive nephropathy. , 1980, Kidney international.
[49] F. S. Wright. Effects of urinary tract obstruction on glomerular filtration rate and renal blood flow , 1982 .
[50] T. Miller,et al. Pyelonephritis: the relationship between infection, renal scarring, and antimicrobial therapy. , 1981, Kidney international.
[51] R. Nagle,et al. Unilateral obstructive nephropathy in the rabbit. I. Early morphologic, physiologic, and histochemical changes. , 1973, Laboratory investigation; a journal of technical methods and pathology.
[52] G. Kalmanson,et al. Pyelonephritis. I. Observations on the Course of Chronic Non-Obstructed Enterococcal Infection in the Kidney of the Rat ‡ , 1961, The Yale journal of biology and medicine.
[53] R. Cooke. Biology of Disease , 1948, The Yale Journal of Biology and Medicine.